Best Orchiectomy Doctors Worldwide — TOP 33

Dr. Bugra Cetin is a board-certified urological surgeon at Uroaesthetic in Istanbul. He specializes in penile prosthesis surgery, genital reconstruction, and male sexual health. Dr. Cetin has performed hundreds of successful penile implant and reconstructive procedures. He holds a PhD in Molecular Medicine and acts as a Rigicon Global Reference Center specialist.

• Member of the International and European Societies for Sexual Medicine.
• Treats erectile dysfunction, Peyronie’s disease, and complex urethral strictures.
• Uses microsurgical and endoscopic techniques for varicocelectomy and bladder procedures.
• Works at Uroaesthetic, a clinic holding ISO and European Board of Urology certifications.

Board-certified urologist specializing in male sexual health and minimally invasive procedures at Menness Wellness Clinic.

• Specialized in andrology and reconstructive procedures
• Expert in testicular surgery and scrotal reconstruction
• Provides patient-centered care focused on quality of life
• Offers gender-affirming urologic procedures

Dr. Tanongsak Panyawirunroj is a leading plastic surgeon at Asia Cosmetic Hospital in Bangkok. He has performed 15,000+ operations throughout his career. Dr. Tanongsak specializes in transformative procedures like rhinoplasty and sexual reassignment surgery. He completed fellowships in the US, Canada, South Korea, and Taiwan.

• Official representative of the Korean Society of Plastic Surgeons.
• Maintains membership with the International Society of Aesthetic Plastic Surgery (ISAPS).
• Performs complex facial feminization (FFS) and orthognathic surgeries.
• Practices at a JCI-accredited facility with a 0% post-surgery complication rate.

Dr. Basri Cakiroglu is an Associate Professor of Urology at Hisar Hospital Intercontinental in Istanbul. He specializes in urooncology, pediatric urology, and male infertility treatment. Dr. Cakiroglu performs complex surgical interventions using the robotic da Vinci system. He works at a JCI-accredited hospital that serves over 500,000 patients annually.

• Performs robotic prostatectomy and kidney-sparing surgeries.
• Treats conditions including varicocele, prostatitis, and polycystic kidney disease.
• Specializes in andrology, infertility, and pediatric urological care.
• Authored numerous medical articles in international and local journals.

Dr. Cenk Acar is a urological surgeon at Hisar Hospital Intercontinental in Istanbul. He has performed over 500 surgeries for urological cancers. He was the first doctor in Turkey to apply bipolar prostate enucleation. Dr. Acar completed a fellowship in robotic and laparoscopic surgery at The Netherlands Cancer Institute.

• Performed over 250 HOLEP procedures for benign prostate enlargement.
• Expert in intraoperative fluorescence imaging for robotic urological surgeries.
• Specializes in sentinel lymph node dissections for prostate cancer treatment.
• Works at a JCI-accredited hospital serving 500,000 patients annually.

Dr. Murat B., Plastik, Rekonstrüktif ve Estetik Cerrahi uzmanıdır. İstanbul’daki Grand Clinic’te görev yapar. Türk Plastik Rekonstrüktif ve Estetik Cerrahi Derneği Yeterlik Belgesi’ne sahiptir. Zonguldak Atatürk Devlet Hastanesi Yanık Ünitesi Sorumlusu olarak görev yapmıştır.

Klinik ilgi alanları: burun estetiği (rinoplasti), liposuction ve vücut şekillendirme, meme estetiği (büyütme, küçültme), yüz estetiği, göz kapağı estetiği ve çene estetiği.

Head of Soft Tissue and Bone Oncology at Sourasky Medical Center – specializes in complex sarcoma cases with 41 years of focused expertise.

• Fellowship-trained at Institut Gustave Roussy in Paris for sarcoma treatment
• ESMO faculty member for sarcoma and bone oncology
• Published extensively on orthopedic oncology outcomes
• Leads ethical committees for cancer treatment protocols

Dr. Mehmet Sarier is a urologist and andrologist at Medical Park Antalya Hospital. He serves as a faculty member at Istinye University Faculty of Medicine. Dr. Sarier specializes in male infertility, sexual health, and robotic surgery. He holds the rank of associate professor since 2020.

• Performs robotic da Vinci prostatectomy and nephrectomy.
• Uses stem cell therapy to treat erectile dysfunction and male infertility.
• Treats complex conditions like varicocele, azoospermia, and Peyronie's disease.
• Practices at the largest private hospital in the Mediterranean region.

Specializes in testicular cancer – Dr. Solak completed his fellowship at Hacettepe University Cancer Institute.

• Over a decade of experience treating testicular cancer
• Trained at MD Anderson Cancer Center – one of the top cancer hospitals
• Works at Hisar Hospital Intercontinental
• Member of Hacettepe University’s Cancer Institute

Dr. Alejandro Lira is a certified urologic surgeon at Hospital de la Familia in Tijuana. He earned his medical degree and surgeon certification from UNAM in Mexico City. Dr. Lira is a member of the Mexican Council of Urologists. He treats conditions like erectile dysfunction, kidney cysts, and prostate hyperplasia. He speaks English fluently and provides surgical care for international patients.

• Certified as a specialist surgeon by the National Autonomous University of Mexico (UNAM).
• Performs prostatectomy, vasectomy reversal, laser lithotripsy, and varicocelectomy.
• Treats male infertility and urological tumors at a CSG-accredited boutique facility.
• Hospital de la Familia sits just 200 yards from the US-Mexico border.

Specializes in gynecologic oncology and laparoscopic surgeries – skilled in scarless and minimally invasive techniques.

• Expert in V-Notes and laparoscopic procedures
• Performs hysteroscopic surgeries for polyp and septum treatments
• Specializes in endometriosis monitoring and surgeries

Dr. Alam Bouhaouli is a urological surgeon at KCM Clinic in Poland. He specializes in the surgical treatment of penile, prostate, and kidney conditions. Dr. Bouhaouli uses microscopic and laser techniques for high-precision interventions. He treats complex oncology cases alongside general urological disorders.

• Performs microsurgical vasectomy reversal and varicocele surgery.
• Specializes in endoscopic prostate vaporization using the Olympus TURIS-P system.
• Conducts laparoscopic kidney and prostate removals at an ISO-certified facility.
• Provides specialized treatments for penile curvature and urinary incontinence.

Prof. Selin Kapan is a professor of general surgery with over 31 years of experience, specializing in complex surgical procedures at İstinye University Liv Hospital Topkapı.

• Author of more than 50 scientific publications in surgical fields
• Member of multiple prestigious surgical associations including the Turkish Surgical Association
• Specializes in minimally invasive and laparoscopic surgical techniques
• Extensive experience in emergency and trauma surgery

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Board-certified surgical oncologist with a focus on precision procedures at Galenia Hospital.

• Specializes in surgical oncology with a title from Universidad Autónoma de México
• Board certified by Conacem until 2030
• Member of the Mexican Society of Oncology (SMEO)
• University teacher at Universidad Anahuac since 2020

Dr. Albayrak specializes in urology at Medipol Mega University Hospital.

• Experienced in performing orchiectomies
• Works at a leading university hospital
• Focuses on urological surgical procedures

Specializes in medical oncology with focused expertise in targeted therapies for complex cancer cases. Dr. Valame is dedicated to both patient care and advancing cancer research.

• DNB in Medical Oncology from Indraprastha Apollo Hospital
• Presented research at ASCO's Gastrointestinal Cancer Symposium
• Expert in the molecular basis of cancer treatments
• Lectured at International Winter School of Oncology